It has been a busy summer but apparently, the MErCuRIC team at the Universitá degli Studi di Torino (UNITO) (pictured above*) never rests. They have just published their 30th MErCuRIC manuscript! Congratulations to the entire team! Find the entire list of MErCuRIC publications here. *Special thanks to Antonina Germano who managed to capture the team […]
This author has yet to write their bio.Meanwhile lets just say that we are proud mercuric contributed a whooping 71 entries.
Entries by mercuric
Our partners at the Universitá degli Studi di Torino have been busy! The research team has recently published MErCuRIC results in five papers. You can download them below. Congratulations to the team of Prof. Alberto Bardelli in the Department of Oncology at UNITO! See the entire list of project publications here.
COLOSSUS, one of MErCuRIC’s “Related Projects” recently hosted a public event in Dublin and invited Coordinator Sandra Van Schaeybroeck to participate. Professor Annette Byrne, Head of the Royal College of Surgeons Ireland (RSCI) Precision Cancer Medicine Group and Coordinator of the EC funded multi-million Euro Colorectal Cancer Research Programme COLOSSUS hosted and chaired the event at the RCSI on […]
Information about PPI in the MErCuRIC study was displayed at a public event launching the NI Cancer Trials Network (NICTN) and NI Cancer Research Consumer Forum (NICRCF) new 5 year Strategy for Personal and Public Involvement in Cancer Research in Northern Ireland. Around 85 research staff, patient representatives and members of the public attended the […]
On the 28th of February 2019, EuropaColon/Digestive Cancers Europe (DICE), one of MErCuRIC’s Related Organisations launched a pan European Colorectal Cancer Screening Awareness Campaign: #mybest10seconds #ECCAM2019. The aim of the campaign is to reach as many citizens across Europe in order to promote the importance of colorectal cancer screening for those over 50 years of […]
Prof. Sandra Van Schaeybroeck from Queen’s University Belfast, the Coordinator of the MErCuRIC project will join researchers involved in the COLOSSUS Project to facilitate a public forum in Dublin on 30 April 2019. In Ireland, April is “Bowel Cancer Awareness Month”. The event: “Colorectal Cancer- How is research in Ireland addressing the challenges?” will take place at […]
Two new research studies with acknowledgement to MErCuRIC have recently been published by our partners at the University of Torino (UNITO): Truini A, Germano G, Bardelli A. Inactivation of DNA repair-prospects for boosting cancer immune surveillance. Genome Med. 2018 Nov 28;10(1):91. doi: 10.1186/s13073-018-0603-9. PubMed PMID: 30486892; PubMed Central PMCID: PMC6260742. Germano G, Amirouchene-Angelozzi N, Rospo G, […]
MErCuRIC Coordinator Prof Sandra Van Schaeybroeck (QUB) and PI Prof Richard Wilson (BHSCT) presented recent project findings at the EORTC NCI AACR symposium in Dublin. This year’s meeting theme was “Molecular Targets and Cancer Therapeutics”. The research poster entitled “MErCuRIC1: A phase 1 Multi-Centre Study of Crizotinib (cMET inhibitor) Combined with Binimetinib (MEK1/2 inhibitor) in […]
The MErCuRIC team of researchers assembled for the Month 60 plenary meeting on November 8th and 9th in Italy. On the 8th the group was met at the Candiolo Cancer Institute (IRCCS) and on the 9th at the Molecular Biotechnology Center of the University of Torino (UNITO). After an overview and report on the project progress […]
Northern Ireland Cancer Research Consumer Forum (NICRCF) member, Ed Goodall, was elected in 2018 to the Patient Advisory Group of the EuropaColon organisation which incorporates researchers and healthcare professionals from nearly 40 countries. The EuropaColon Patient Advisory Group held their most recent meeting in October 2018 in Munich in conjunction with that of the European Society […]
MErCuRIC is funded by the European Community’s Framework Programme Seven (FP7) under contract #602901. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.